• 1. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 2. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400

Comprehensive Guide to (3S)-3-ethylmorpholine hydrochloride (CAS No. 218594-88-8): Properties, Applications, and Market Insights

(3S)-3-ethylmorpholine hydrochloride (CAS No. 218594-88-8) is a specialized chiral compound widely recognized for its role in pharmaceutical synthesis and fine chemical applications. This morpholine derivative features a stereospecific ethyl group at the 3-position, enhancing its utility in asymmetric synthesis. With the growing demand for enantiomerically pure compounds in drug development, (3S)-3-ethylmorpholine HCl has gained prominence as a key intermediate for APIs (Active Pharmaceutical Ingredients).

The molecular structure of (3S)-3-ethylmorpholine hydrochloride combines the morpholine ring system with an ethyl substituent, contributing to its unique physicochemical properties. Its hydrochloride salt form improves solubility in polar solvents, making it particularly valuable for reactions requiring aqueous conditions. Researchers frequently inquire about "synthesis of (3S)-3-ethylmorpholine" or "chiral morpholine derivatives uses," reflecting the compound's relevance in modern organic chemistry.

In pharmaceutical applications, (3S)-3-ethylmorpholine hydrochloride serves as a crucial building block for various therapeutic agents. Its chiral nature makes it especially valuable for developing stereoselective drugs, addressing the increasing focus on enantiopure medications in the industry. Current trends show rising searches for "chiral auxiliaries in drug synthesis" and "morpholine-based pharmaceuticals," highlighting the compound's significance in cutting-edge research.

The global market for (3S)-3-ethylmorpholine HCl has shown steady growth, driven by expanding pharmaceutical R&D and the need for specialized intermediates. Industry reports indicate particular demand from regions with strong generic drug manufacturing capabilities. Frequently searched terms like "suppliers of 218594-88-8" and "pricing trends for ethylmorpholine derivatives" demonstrate commercial interest in this compound.

From a technical perspective, (3S)-3-ethylmorpholine hydrochloride typically appears as a white to off-white crystalline powder with good stability under standard storage conditions. Its physicochemical parameters (including melting point, solubility profile, and optical rotation) make it suitable for various synthetic protocols. Laboratory professionals often search for "handling precautions for morpholine salts" and "analytical methods for chiral amines" when working with this material.

Recent scientific literature highlights innovative applications of (3S)-3-ethylmorpholine derivatives in medicinal chemistry. The compound's scaffold has shown potential in designing novel bioactive molecules, particularly in central nervous system (CNS) drug development. This aligns with growing public interest in "new treatments for neurological disorders" and "chiral drug development 2024" as trending search topics.

Quality control of (3S)-3-ethylmorpholine hydrochloride requires rigorous analytical techniques, including HPLC purity testing and chiral separation methods. The pharmaceutical industry's emphasis on "ICH guidelines for impurities" and "specifications for chemical intermediates" reflects the stringent standards applied to such compounds. Manufacturers typically provide detailed certificates of analysis to ensure compliance with regulatory requirements.

Environmental and safety considerations for (3S)-3-ethylmorpholine HCl follow standard laboratory chemical protocols. While not classified as hazardous under normal handling conditions, proper laboratory safety measures should always be observed. This practical aspect generates frequent queries about "storage conditions for amine hydrochlorides" and "waste disposal of nitrogen-containing compounds."

The future outlook for (3S)-3-ethylmorpholine hydrochloride appears promising, with potential expansions into new therapeutic areas and synthetic methodologies. As the pharmaceutical industry continues to prioritize chiral technology and green chemistry principles, this compound is well-positioned to maintain its relevance. Emerging search trends like "continuous flow synthesis of chiral amines" and "biocatalytic approaches to morpholine derivatives" suggest exciting directions for further development.

For researchers and procurement specialists, understanding the technical specifications and supply chain dynamics of (3S)-3-ethylmorpholine hydrochloride (CAS 218594-88-8) is essential. The compound's unique combination of stereochemical properties and synthetic versatility ensures its continued importance in advanced chemical synthesis and drug discovery initiatives worldwide.

• 904316-92-3(3-Oxa-8-azabicyclo[3.2.1]octane hydrochloride)
• 1227917-52-3((3R)-3-(propan-2-yl)morpholine hydrochloride)
• 218595-15-4((S)-3-Isopropylmorpholine hydrochloride)
• 399580-64-4(2-(morpholin-3-yl)ethan-1-ol)
• 55265-24-2(3-ethylmorpholine)
• 74572-05-7((3R)-3-ethylmorpholine)
• 761460-05-3((S)-2-(Morpholin-3-yl)ethanol)
• 74811-65-7(Croscarmellose sodium)
• 748117-01-3((3S)-3-ethylmorpholine)
• 917572-32-8((R)-2-(Morpholin-3-yl)ethanol)